Compass Therapeutics, Inc.
NASDAQ:CMPXBiotechnology
Healthcare
$0.61 -1.46%
-$0.03 today
- Market cap
- $109.26M
- Beta
- 0.74
- P/E (TTM)
- -5.5
- EPS (TTM)
- -$0.37
52W Low $1.61High $6.88
Volume 2.90M
Average 7.64M
Price history
Compass Therapeutics, Inc. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
-87.69%
Period high
$6.69
Period low
$0.61
Latest
$0.61
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| SC 13G | Nov 10, 2026 | Nov 10, 2026 | |
| 8-K | Nov 9, 2026 | Nov 9, 2026 | |
| 10-Q | Nov 9, 2026 | Nov 9, 2026 | |
| 4 | Oct 2, 2026 | Oct 2, 2026 | |
| 4 | Sep 25, 2026 | Sep 25, 2026 | |
| 8-K | Sep 22, 2026 | Sep 22, 2026 | |
| SC 13G/A | Aug 14, 2026 | Aug 14, 2026 | |
| SC 13G | Aug 7, 2026 | Aug 7, 2026 | |
| 8-K | Aug 6, 2026 | Aug 6, 2026 | |
| 10-Q | Aug 6, 2026 | Aug 6, 2026 | |
| 8-K | Jul 1, 2026 | Jul 1, 2026 | |
| 8-K | Jun 23, 2026 | Jun 22, 2026 | |
| 8-K | Jun 11, 2026 | Jun 11, 2026 | |
| SC 13G/A | May 15, 2026 | May 15, 2026 | |
| 10-Q | May 5, 2026 | May 5, 2026 |
Competitors
Who does Compass Therapeutics, Inc. compete with?
Open similar companies to compare their filings and price history.
Competitors
Peer companies in the same sector
Questions
Filing questions
Common questions about CMPX's filings, answered from its disclosures.
What is the latest CMPX filing?
The latest filing shown is SC 13G dated Nov 10, 2026.
How many recent filings does CMPX have?
Intrinsic Alpha currently shows 20 recent filings for CMPX.
Continue the stock analysis
Jump to another research area for this company.